This could be an off target protein.
Lupus is much more prevalent in females. Depleting androgens via castration increases disease and mortality in male NZBxNZWF1 (BWF1) mice, suggesting androgens are protective. We have found that treatment of male BWF1 mice with CD103-neutralizing antibody induces disease and increases mortality suggesting CD103+ cells are important for disease protection in males. Mesenteric lymph node (MLN) CD103+ dendritic cells (CD103DC) from castrated male mice exhibit decreased ability to induce conversion of CD4+Foxp3+ cells (Tregs) in vitro and decreased expression of RALDH2, an enzyme involved in retinoic acid synthesis (hallmark of CD103DC function) vs control mice. Also, castrated BWF1 male mice have significantly decreased circulating and peripheral LN Tregs vs control mice, suggesting androgens may affect Tregs via an effect on CD103DC. We have found CD103DC express androgen receptor (AR) mRNA levels that are lower than splenic macrophages (positive controls), but higher than splenic myeloid DC (negative controls) suggesting that androgens could have a direct effect on CD103DC. To determine whether signaling through the AR is required for androgen-mediated protection and CD103DC function, male BWF1 mice were treated with flutamide (AR inhibitor). Male mice treated with flutamide exhibited increased disease incidence and severity, and decreased CD103DC function including a decreased ability to induce conversion of Tregs in vitro and decreased expression of RALDH2 mRNA. Taken together, these data suggest that androgens may influence immunoregulation via a direct effect on CD103DC function and may, at least in part, mediate protection from lupus through this mechanism.